Dublin, Nov. 21, 2025 (GLOBE NEWSWIRE) -- The "Naproxen Sodium (CAS 26159-34-2) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029" report has been added to ...
Dr. Reddy’s Labs is relaunching its over-the-counter naproxen sodium tablets, a store-brand equivalent of Aleve. The product is available in 220-mg dosage strength. “The re-launch of Dr. Reddy’s ...
1 Pediatric Headache Fellow, Department of Pediatric Neurology, Center for Headache and Pain, Neurological Institute, Cleveland Clinic Foundation, 778 Long Ridge Rd, Stamford, CT 06902, USA. 2 ...
Both sumatriptan (Imitrex) and naproxen sodium (Aleve, others) are used to treat a migraine attack. A new but not yet commercially available combination tablet containing sumatriptan 85 mg plus ...
When it comes to managing mild pain at home, there’s a strong probability you’ve already got a few types of OTC anti-inflammatories stocked in your medicine cabinet. Ibuprofen (Advil or Motrin), ...
WASHINGTON (Reuters) - Naproxen, a common, over-the-counter pain reliever used for arthritis and other aches and pains, appears to be safe for the heart, despite warnings, researchers reported on ...
PRINCETON, N.J., July 02, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that it received U.S. Food and Drug Administration (FDA) approval for ...
HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as “Dr.
NEW YORK (Reuters Health) - Migraine sufferers may be able to get sufficient relief without turning to prescription drugs, according to two new studies. The studies, published in the latest issue of ...
An Alzheimer’s disease prevention trial was suspended after researchers said there were more heart attacks and strokes among patients taking naproxen, an over-the-counter pain reliever in use for 28 ...
(RTTNews) - Dr. Reddy's Laboratories Ltd. (RDY) announced Thursday the first-to-market launch of Naproxen and Esomeprazole Magnesium Delayed-Release Tablets in the U.S. market. The tablets are a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results